FDA — authorised 15 December 1986
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Lamprene in United States
FDA authorised Lamprene on 15 December 1986
Marketing authorisations
FDA — authorised 15 December 1986
- Application: NDA019500
- Marketing authorisation holder: NOVARTIS
- Local brand name: LAMPRENE
- Indication: CAPSULE — ORAL
- Status: approved
Lamprene in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Lamprene approved in United States?
Yes. FDA authorised it on 15 December 1986; FDA authorised it on 15 December 1986.
Who is the marketing authorisation holder for Lamprene in United States?
NOVARTIS holds the US marketing authorisation.